Editorial
The FDA in 2006: reasons for optimism.
Article
The rosiglitazone story--lessons from an FDA Advisory Committee meeting.
N. Engl. J. Med. 2007 Aug 30; 357 (9): 844-6.
Article
A lifecycle approach to the evaluation of FDA approval methods and regulatory actions: opportunities provided by a new IOM report.
JAMA. 2012 Jun 20; 307 (23): 2491-2.